Opko Health Inc (OPK)

Feb 21, 2025

OPKO Health (OPK) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Feb 21, 2025

Feb 18, 2025

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN

Feb 18, 2025

Feb 13, 2025

OPKO Health to Announce Q4 2024 Financial Results - TipRanks

Feb 13, 2025

Feb 13, 2025

OPKO Health, Inc. to Report Q4 and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq

Feb 13, 2025

Feb 13, 2025

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 - GlobeNewswire

Feb 13, 2025

Feb 13, 2025

OPKO Health Sets Critical Q4 Earnings Date: What The Numbers Will Reveal - StockTitan

Feb 13, 2025

Feb 12, 2025

Hidden Gems of Nasdaq: Why These Under-$5 Stocks Are Catching Eye - MotoPaddock

Feb 12, 2025

Feb 12, 2025

Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy? - Insider Monkey

Feb 12, 2025

Feb 11, 2025

10 Best Nasdaq Stocks Under $5 to Buy - Insider Monkey

Feb 11, 2025

Feb 08, 2025

Y.D. More Investments Ltd Has $2.06 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Feb 08, 2025

Feb 08, 2025

OPKO Health (NASDAQ:OPK) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Feb 08, 2025

Feb 06, 2025

Insiders continue to buy OPKO Health, Inc. (NASDAQ:OPK) and now own 52% shares - Simply Wall St

Feb 06, 2025

Feb 05, 2025

Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud - Grizzly Reports

Feb 05, 2025

Feb 01, 2025

OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 47,537 Shares - MarketBeat

Feb 01, 2025

Jan 28, 2025

Opko health CEO Phillip Frost buys $70,060 in stock By Investing.com - Investing.com Australia

Jan 28, 2025

Jan 28, 2025

Opko health CEO Phillip Frost buys $70,060 in stock - MSN

Jan 28, 2025

Jan 28, 2025

Clinical Laboratory Tests Market Generated Opportunities, - openPR

Jan 28, 2025

Jan 28, 2025

Clinical Laboratory Tests Market Key Players AnalysisARUP - openPR

Jan 28, 2025

Jan 24, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 24, 2025

Jan 22, 2025

Billionaire Phillip Frost's health care company settles case with federal government - The Business Journals

Jan 22, 2025

Jan 20, 2025

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Insider Monkey

Jan 20, 2025

Jan 20, 2025

12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey

Jan 20, 2025

Jan 20, 2025

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Jan 20, 2025

Jan 20, 2025

3 Stocks That Wall Street Insiders Can't Stop Buying - MSN

Jan 20, 2025

Jan 19, 2025

BioReference faces $704,349 fine for medically unnecessary blood tests - MSN

Jan 19, 2025

Jan 19, 2025

Opko health CEO Phillip Frost buys $220,425 in common stock - MSN

Jan 19, 2025

Jan 18, 2025

OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com

Jan 18, 2025

Jan 17, 2025

Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Canada

Jan 17, 2025

Jan 17, 2025

Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat

Jan 17, 2025

Jan 17, 2025

BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today

Jan 17, 2025

Jan 17, 2025

BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law

Jan 17, 2025

Jan 16, 2025

Opko health CEO Phillip Frost buys $740,850 in stock By Investing.com - Investing.com South Africa

Jan 16, 2025

Jan 16, 2025

Barclays PLC Acquires 329,870 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jan 16, 2025

Jan 15, 2025

Opko health CEO Phillip Frost buys $740,850 in stock - Investing.com India

Jan 15, 2025